£9.51m
+96%vs Dec 2024Active10641754Private limited companyAbingdon
PATHIOS THERAPEUTICS LIMITED
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Pathios Therapeutics Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Pathios Therapeutics Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
PATHIOS THERAPEUTICS LIMITED is an active private limited company (company number 10641754) incorporated on 27 February 2017, registered in Abingdon. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of £9.51m and cash of £6.25m, with 9 employees on average. Net assets rose 96% on the prior period (£4.85m).
Peer position · net assets
By net assets it sits in the top quarter of 152 comparable companies in Oxford (median £10k, upper quartile £474k).
02
Ownership and control
No active person with significant control is registered.
- Dr Someit Singh Sidhu
- has significant influence or control
- Canaan Xi L.P.
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 27 February 20179 yrs ago
- Next accounts due
- 30 September 2027in 339 days
- Confirmation statement due
- 13 March 2027in 138 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Small
- Size band
- MicroCompanies Act thresholds
05
Financials
£6.25m
+92%vs Dec 2024Not reported
9
+29%vs Dec 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £9.51m | £6.25m | — | £1.39m | — | −£7.48m | 9 |
| 31 December 2024 | £4.85m | £3.25m | — | £677k | — | −£6.74m | 7 |
| 1 January 2024 | — | — | — | — | — | — | — |
| 31 December 2023 | £3.77m | £2.78m | — | £697k | — | −£6.07m | 8 |
| 1 January 2023 | — | — | — | — | — | — | — |
Current ratio6.04Current assets ÷ creditors within one year
Cash per employee£695kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £9,508,621 at 31 December 2025
- Net assets up 10% or more on the prior period+96.1% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 6.04
- Cash at bank of £50,000 or moreCash £6,250,516
- Three or more accounting periods on record5 periods on record
- Incorporated five or more years agoIncorporated 27 February 2017
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 339 days
- Confirmation statement duein 138 days
- Accounts period endNet assets £9.51m · small accounts
- Accounts period endNet assets £4.85m · small accounts
- Accounts period end
- Accounts period endNet assets £3.77m · small accounts
- Accounts period end
- Incorporated
08
Similar companies in Oxford
- SPYBIOTECH LIMITEDOxford · inc. Mar 2017
- BERGENBIO LIMITEDOxford · inc. Jan 2017
- OXFORD MEDICAL PRODUCTS LIMITEDWitney · inc. Dec 2016
- OXFORD MOLECULAR BIOSENSORS LIMITEDThame · inc. Jun 2017
- ENARA BIO LIMITEDOxford · inc. Nov 2016
- MOA TECHNOLOGY LIMITEDOxford · inc. Aug 2017
All companies incorporated on 27 February 2017 · in Feb 2017.
09
Reminders for PATHIOS THERAPEUTICS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.